Hill-Rom, Batesville, IN, has launched CareSelections by Hill-Rom. CareSelections is a new offering comprised of economical, simple-to-use, and low-maintenance products targeted to help health care providers, especially in long-term acute care facilities, achieve positive clinical and efficiency outcomes. The new line includes low-air-loss wound care and pulmonary therapy surfaces to help in the prevention and treatment of pressure ulcers, as well as to provide rotational therapy for patients with pulmonary complications. Also included are a variety of bariatric beds, therapy surfaces, and accessories, such as wheelchairs, to help meet the needs of bariatric patients.
[black up pointing small triangle] Information:http://www.hill-rom.com
Kestrel Health Information, Inc, Bristol, VT, has changed the name of its flagship publication, The Kestrel Wound Product Sourcebook to WoundSource, beginning with the 2004 edition. The directory was renamed to correlate the print publication to its online companion, http://www.woundsource.com. Both resources offer databases of wound care products and company information.
[black up pointing small triangle] Information:http://www.kestrelhealthinfo.com
Swiss-American Products, Inc, Dallas, TX, has introduced the Collective Learning Education and Resources (CLEAR Choice) program, designed to give health care providers additional resources and knowledge related to skin care and wound prevention and treatment. Swiss-American Products developed the program to also help assisted living facilities, hospices, home health care groups, independent living facilities, pharmacies, and intermediate- and long-term-care facilities improve their ability to meet patient's clinical needs and manage budgets at the same time.
CLEAR Choice provides a comprehensive line of skin and wound care products, a network of board-certified wound care consultants, and assistance with policy and procedure development related to skin and wound care.
[black up pointing small triangle] Information:http://www.elta.net
Bioelectronics Corporation, Frederick, Md, has begun shipping its new flexible ActiPatch Therapy dermal patches. The new product was presented recently at the annual meeting of the American Society of Plastic Surgeons in Vancouver, BC. Incorporating a flexible model and adhesion method, the patches conform to the body to enhance the ease of wear and comfort.
ActiPatch Therapy is a dermal patch with an embedded microchip that delivers weeks of continuous therapy. The product is the miniaturized equivalent of the pulsed electromagnetic energy machines prescribed by health care providers to reduce swelling, relieve pain, and enhance the healing of surgical incisions, accidental wounds, sprains, strains, and chronic wounds (such as pressure ulcers).
[black up pointing small triangle] Information:http://www.bioelectronicscorp.com
Alltracel Pharmaceuticals, Dublin, Ireland, has launched its new SEAL-ON line of consumer first aid products that stop bleeding fast by helping the blood coagulate quicker. SEAL-ON is the first brand of first aid products in the United States to feature the patented m-doc-microdispersed oxidized cellulose-a natural powdered hemostatic substance derived from pure cotton that stops bleeding from minor wounds, scrapes, and nosebleeds. To avoid skin irritation or allergic reactions when applied to open wounds, m-doc is pH balanced, biocompatible, and hypoallergenic.
The initial range of SEAL-ON products that will be available in the United States includes:SEAL-ON Spray, a spray delivery system that applies m-doc directly to wound; SEAL-ON Nasal Sponges, specially designed nasal sponges impregnated with m-doc to expand and absorb the flow of blood and to act on the source of the bleeding to stop it quickly, and SEAL-ON Bandages, sterile adhesive bandages that contain m-doc in the absorbent pads to quickly stop bleeding of cuts, scrapes, and surface wounds.
[black up pointing small triangle] Information:http://www.seal-on.com
Inyx, Inc, New York, NY, plans to introduce a private label wound care irrigation product that is based on an advanced aerosol drug delivery technology utilized by the company's wholly owned United Kingdom subsidiary, INyX Pharma Limited. Inyx hopes to launch the product in the U.K. before the end of 2004. The company is currently in discussions with possible marketing partners.
In addition, Inyx is planning to develop a second-generation wound-care product, with commercial launch anticipated in the first half of 2005.
[black up pointing small triangle] Information:http://www.inyxinc.com